Inhibrx Biosciences Income Statement (2023-2025) | INBX

Income Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter) 0.03M0.12M1.63M0.10M0.10M1.30M
Operating items
Research & Development (Quarter) 34.11M38.06M82.09M63.85M67.63M38.89M33.37M36.88M22.27M28.54M25.35M
Selling, General & Administrative (Quarter) 7.26M7.89M7.83M9.97M93.37M7.90M16.66M6.02M6.42M5.28M5.57M
Operating Expenses (Quarter) 41.37M45.95M89.92M73.83M161.00M46.80M50.03M42.90M28.69M33.81M30.92M
Operating Income (Quarter) -41.34M-45.83M-88.29M-73.83M-160.90M-46.80M-49.93M-42.90M-27.39M-33.81M-30.92M
EBIT (Quarter) -41.34M-45.83M-88.29M-73.83M-160.90M-46.80M-49.93M-42.90M-27.39M-33.81M-30.92M
Non-operating items
Interest & Investment Income (Quarter) 2.41M2.32M4.70M3.30M2.74M2.89M2.00M2.33M2.12M1.78M1.31M
Other Non Operating Income (Quarter) -0.22M-0.14M-0.16M-0.06M0.03M0.04M0.06M-0.05M-0.25M-0.05M-0.04M
Non Operating Income (Quarter) -5.71M-5.96M-3.69M-4.88M2,018.91M2.93M2.06M-0.41M-1.26M-1.44M-1.91M
Net income details
EBT (Quarter) -47.05M-51.79M-91.97M-78.71M1,858.01M-43.86M-47.87M-43.31M-28.65M-35.26M-32.83M
Tax Provisions (Quarter) 0.01M0.00M-0.00M0.00M0.00M
Profit After Tax (Quarter) -47.05M-51.79M-93.60M-78.71M1,858.01M-43.86M-47.87M-43.31M-28.65M-35.26M-32.83M
Income from Continuing Operations (Quarter) -47.05M-51.79M-91.97M-78.71M1,858.01M-43.86M-47.87M-43.31M-28.65M-35.26M-32.83M
Consolidated Net Income (Quarter) -47.05M-51.79M-91.97M-78.71M1,858.01M-43.86M-47.87M-43.31M-28.65M-35.26M-32.83M
Income towards Parent Company (Quarter) -47.05M-51.79M-91.97M-78.71M1,858.01M-43.86M-47.87M-43.31M-28.65M-35.26M-32.83M
Net Income towards Common Stockholders (Quarter) -47.05M-51.79M-91.97M-78.71M1,858.01M-43.86M-47.87M-43.31M-28.65M-35.26M-32.83M
Additional items
EPS (Basic) (Quarter) -4.31-4.39-7.81-5.77127.10-2.84-3.23-2.80-1.85-2.28-2.12
EPS (Diluted) (Quarter) -4.31-4.39-7.81-5.77125.48-2.84-3.19-2.80-1.85-2.28-2.12
Shares Outstanding (Quarter) 10.91M11.79M11.78M13.64M14.62M15.47M14.80M15.47M15.47M15.48M15.49M
Shares Outstanding (Diluted) (Quarter) 10.91M11.79M11.78M13.64M14.81M15.47M14.98M15.47M15.47M15.48M15.49M
EBITDA (Quarter) -41.34M-45.83M-88.29M-73.83M-160.90M-46.80M-49.93M-42.90M-27.39M-33.81M-30.92M
Interest Expenses (Quarter) 7.91M8.15M8.24M8.13M5.40M1.99M9.26M8.70M7.99M5.81M
Tax Rate (Quarter) -0.010.000.000.00-0.01